Skip to content
411 PRESS
WarningRecall #D-0258-2026Drug / Pharmaceutical

Advanced Pharmaceutical Technology Recalls TESTO-100 CIII (testosterone 100 mg)

Advanced Pharmaceutical Technology, Inc. · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01

Reason for Recall

Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Advanced Pharmaceutical Technology, Inc. initiated the recall on October 3, 2025 affecting 22,843 pellets. Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Advanced Pharmaceutical Technology, Inc. for further instructions.

Independent news on labor, safety, and accountability.